SeaStar Medical Holding Corp (ICUCW) stock
ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)
Close on Oct 30, 2026Market cap $9.87MP/E –Yield –
SeaStar Medical total assets
Total assets on the balance sheet at the end of each period.
SeaStar Medical's total assets was $8.65M at Jun 30, 2026. For fiscal 2025 it was $14.16M, up 204.0% from the year before. The highest annual figure on record is $14.16M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.16M | +204.0% |
| FY2024 | Dec 31, 2024 | $4.66M | +32.6% |
| FY2023 | Dec 31, 2023 | $3.51M | +15.6% |
| FY2022 | Dec 31, 2022 | $3.04M | +403.8% |
| FY2021 | Dec 31, 2021 | $603.00K | +124.0% |
| FY2020 | Dec 31, 2020 | $269.21K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.65M | +3.2% |
| Q1 FY2026 | Mar 31, 2026 | $11.26M | -20.7% |
| Q4 FY2025 | Dec 31, 2025 | $14.16M | +204.0% |
| Q3 FY2025 | Sep 30, 2025 | $15.53M | +238.6% |
| Q2 FY2025 | Jun 30, 2025 | $8.38M | +141.8% |
| Q1 FY2025 | Mar 31, 2025 | $14.20M | +83.5% |
| Q4 FY2024 | Dec 31, 2024 | $4.66M | +32.6% |
| Q3 FY2024 | Sep 30, 2024 | $4.59M | +82.9% |
| Q2 FY2024 | Jun 30, 2024 | $3.47M | +33.6% |
| Q1 FY2024 | Mar 31, 2024 | $7.74M | +112.2% |
| Q4 FY2023 | Dec 31, 2023 | $3.51M | +15.6% |
| Q3 FY2023 | Sep 30, 2023 | $2.51M | -97.7% |
| Q2 FY2023 | Jun 30, 2023 | $2.60M | -97.6% |
| Q1 FY2023 | Mar 31, 2023 | $3.65M | -96.6% |
| Q4 FY2022 | Dec 31, 2022 | $3.04M | +403.8% |
| Q3 FY2022 | Sep 30, 2022 | $107.34M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | $105.95M | -0.5% |
| Q1 FY2022 | Mar 31, 2022 | $105.96M | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | $603.00K | +124.0% |
| Q3 FY2021 | Sep 30, 2021 | $106.20M | – |
| Q2 FY2021 | Jun 30, 2021 | $106.53M | – |
| Q1 FY2021 | Mar 31, 2021 | $106.83M | – |
| Q4 FY2020 | Dec 31, 2020 | $269.21K | – |